Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Humira biosimilars available at up to 80 percent discount in Europe: AbbVie

November 2, 2018 2:11 PM
79 0

(Reuters) - AbbVie Inc (ABBV.N) said on Friday rival biosimilar versions of its best-selling drug Humira were available in Europe at discounts ranging from 10 percent to 80 percent.

The company expects 2019 price of Humira in the United States to be very similar to 2018 rates, AbbVie executives said on a conference call.

Read more

Share in social networks:

Comments - 0